Zydus Lifesciences Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For ZYDUSLIFE, that strike is ₹1,150. Spot at ₹1,120 is 2.6% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The options market for ZYDUSLIFE shows a max‑pain strike at ₹1150. This is the price where the combined loss of option writers (calls and puts) would be minimized, acting like a magnetic anchor as expiration approaches.
Spot vs Max Pain Gap
The current spot of ₹1120 sits about 2.6 % below the max‑pain level, indicating a downward bias relative to the theoretical convergence point. If the underlying rallies toward ₹1150, the gap will narrow, potentially triggering a pull‑back in price momentum.
Shift Signal
The shift metric is flat (0), meaning there has been no recent movement of the max‑pain level. Writers are likely maintaining their existing exposure, keeping the magnet at ₹1150 unchanged while market participants assess price direction.
Expiry Context
Max‑pain reflects the point where the net payoff to all option writers is smallest; it does not guarantee the underlying will end there, but historically many stocks gravitate toward this strike in the final days of the contract. During the expiry week, traders commonly see increased option‑related activity, and price action often oscillates around the pain point as positions are unwound.
Data Note
With 25 days left until the September 29 expiry, the spot price remains ₹30 below the max‑pain strike, a modest distance that could be bridged if upward pressure intensifies.
Data as of 2026-09-04